To determine whether the attenuation of liver tumors at the early stage by ar knockout is only specific to kras-induced liver tumors, it will be interesting to investigate if ARKO could also suppress liver tumors induced by other oncogenes. This evidence concerns the gene KRAS and Neoplasm of the liver.